ROBINS CHAD M (CEO and Chairman) sold 17.0% of their position (470.17K shares) of ADAPTIVE BIOTECHNOLOGIES CORP on the open market
Open‑market sale worth $6.19M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/13/2026ACC: 0001780649-26-000007
DirectorOfficer· CEO and Chairman
Since Jun 2019
-470.17K
Net shares
Net seller
$6.19M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
470.17K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−140.57K
Price / share
$13.17
Trade value
$1.85M
% of position
5.1%
3/11/2026
2.77M→2.63M
Common Stock
Direct
Shares
−329.60K
Price / share
$13.17
Trade value
$4.34M
% of position
12.5%
3/11/2026
2.63M→2.30M
Total
Net shares
−470.17K
Net value
-$6.19M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2026 | S · Sale | −140.57K | $13.17 | $1.85M | 5.1% | 2.77M | 2.63M |
| Common Stock Direct | 3/11/2026 | S · Sale | −329.60K | $13.17 | $4.34M | 12.5% | 2.63M | 2.30M |
| Total | −470.17K | -$6.19M | ||||||
Derivative Transactions0
No derivative transactions reported